Literature DB >> 16313334

Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.

Igor B Resnick1, Ali Abdul Hai, Michael Y Shapira, Menachem Bitan, Eli Hershkovitz, Arie Schwartz, Miriam Ben-Harush, Reuven Or, Shimon Slavin, Joseph Kapelushnik.   

Abstract

Childhood cerebral form of X-linked adrenoleukodystrophy (X-ALD) is a rapidly progressive demyelinating condition affecting the cerebral white matter, which rapidly leads to total disability and death. The only known curative treatment for this condition is allogeneic hematopoietic stem cell transplantation (HSCT). Procedure-related toxicity is assumed to be the cause of death of patients with X-ALD. Three cases of ALD successfully transplanted with the use of non-myeloablative fludarabine based conditioning are described. Patients showed smooth peri-bone marrow transplantation course with fast and stable engraftment. In the 3- to 5 yr follow-up period, patients showed no deterioration in their clinical and neurological condition. Levels of very long chain fatty acids were very variable and had a tendency to decrease in at least one of the three patients. In another patient, an improvement of magnetic resonance imaging changes was found. Non-myeloablative HSCT should be considered as an early treatment for X-ALD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313334     DOI: 10.1111/j.1399-0012.2005.00411.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

Review 1.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

2.  Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy.

Authors:  Reena V Kartha; Jie Zhou; Lisa Basso; Henning Schröder; Paul J Orchard; James Cloyd
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

3.  Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.

Authors:  Alex R Kemper; Jeffrey Brosco; Anne Marie Comeau; Nancy S Green; Scott D Grosse; Elizabeth Jones; Jennifer M Kwon; Wendy K K Lam; Jelili Ojodu; Lisa A Prosser; Susan Tanksley
Journal:  Genet Med       Date:  2016-06-23       Impact factor: 8.822

Review 4.  The role of microglia in human disease: therapeutic tool or target?

Authors:  Nathalie Cartier; Coral-Ann Lewis; Regan Zhang; Fabio M V Rossi
Journal:  Acta Neuropathol       Date:  2014-08-09       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.